SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2021

Apr 29, 2021

==> picture [205 x 82] intentionally omitted <==

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : investors@solara.com www.solara.co.in

April 29, 2021

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051

Scrip Code: 541540

Scrip Code: SOLARA

Dear Sirs,

Sub: Announcement of Board Meeting under Regulation 29 (1) of SEBI Listing Regulations

This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 6, 2021 to inter alia consider and approve, the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2021 and recommendation of final dividend, if any, amongst other matters.

In accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from April 1, 2021 till 48 hours after the announcement of financial results i.e. upto May 8, 2021 (both days inclusive).

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

==> picture [146 x 39] intentionally omitted <==

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942